This genetic test newly developed to predict lung cancer survival has the potential to enhance patients’ quality of life for those who have a good prognosis by avoiding chemotherapy, as well as being a cost saving for hospitals.
This genetic test newly developed to predict lung cancer survival has the potential to enhance patients’ quality of life for those who have a good prognosis by avoiding chemotherapy, as well as being a cost saving for hospitals.